Bioplastics and chemicals derived from biological raw materials are being hailed as the next big thing for the chemical industry, a development that could have a huge impact on both that industry and the many others that depend on it.
The pharmaceutical industry is suffering. Expiring patents, increasing demands from regulators and decreasing healthcare budgets are putting companies under pressure, and the industry has to walk a narrow tightrope between keeping profitability up and quickly developing attractive medications....
Now that the dust of the global financial crisis has begun to settle, many business leaders are wondering what their next steps should be in the lingering atmosphere of uncertainty. With the heavy rounds of cost-cutting finished, “Growth now” is the new mantra.
In this exclusive interview, Harri Kerminen, president and chief executive of Kemira, provides an insight into the participatory culture of the Finnish global chemicals group and reveals his thoughts on a changing portfolio, sustainability and how to deal with a challenging economic climate.
"Nature imitates art", argued Oscar Wilde, but today’s scientists imitate nature. This article examines the remarkable field of biomimicry, in which nature’s ingenious solutions to problems that have long baffled engineers are imitated and adopted.